1. Home
  2. AYTU vs PSHG Comparison

AYTU vs PSHG Comparison

Compare AYTU & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • PSHG
  • Stock Information
  • Founded
  • AYTU N/A
  • PSHG 2010
  • Country
  • AYTU United States
  • PSHG Greece
  • Employees
  • AYTU N/A
  • PSHG N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • PSHG Marine Transportation
  • Sector
  • AYTU Health Care
  • PSHG Consumer Discretionary
  • Exchange
  • AYTU Nasdaq
  • PSHG Nasdaq
  • Market Cap
  • AYTU 23.0M
  • PSHG 25.2M
  • IPO Year
  • AYTU N/A
  • PSHG N/A
  • Fundamental
  • Price
  • AYTU $2.19
  • PSHG $2.01
  • Analyst Decision
  • AYTU Strong Buy
  • PSHG
  • Analyst Count
  • AYTU 3
  • PSHG 0
  • Target Price
  • AYTU $9.17
  • PSHG N/A
  • AVG Volume (30 Days)
  • AYTU 182.8K
  • PSHG 125.2K
  • Earning Date
  • AYTU 11-13-2025
  • PSHG 11-07-2025
  • Dividend Yield
  • AYTU N/A
  • PSHG N/A
  • EPS Growth
  • AYTU N/A
  • PSHG 5.84
  • EPS
  • AYTU N/A
  • PSHG 1.56
  • Revenue
  • AYTU $66,382,000.00
  • PSHG $84,042,000.00
  • Revenue This Year
  • AYTU N/A
  • PSHG N/A
  • Revenue Next Year
  • AYTU $29.12
  • PSHG $17.95
  • P/E Ratio
  • AYTU N/A
  • PSHG $1.28
  • Revenue Growth
  • AYTU 1.84
  • PSHG N/A
  • 52 Week Low
  • AYTU $0.95
  • PSHG $1.31
  • 52 Week High
  • AYTU $2.82
  • PSHG $2.34
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 46.28
  • PSHG 60.05
  • Support Level
  • AYTU $2.23
  • PSHG $1.98
  • Resistance Level
  • AYTU $2.31
  • PSHG $2.16
  • Average True Range (ATR)
  • AYTU 0.12
  • PSHG 0.08
  • MACD
  • AYTU -0.02
  • PSHG 0.01
  • Stochastic Oscillator
  • AYTU 14.04
  • PSHG 54.55

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

About PSHG Performance Shipping Inc.

Performance Shipping Inc is a provider of shipping transportation services through its ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying containerized cargo along various shipping routes. It owns and operates six Aframax tanker vessels.

Share on Social Networks: